Follow-up Study of 14 Cases of Testicular tumor.
- Author:
Byong Soo LEE
1
;
Jin Moo LEE
Author Information
1. Department of Urology, College of Medicine, Yonsei University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
testicular tumor
- MeSH:
Drug Therapy;
Follow-Up Studies*;
Germ Cells;
Humans;
Lymphoma;
Neoplasms, Germ Cell and Embryonal;
Radioimmunoassay;
Reticulum;
Seminoma;
Teratocarcinoma;
Teratoma;
Testicular Neoplasms
- From:Korean Journal of Urology
1984;25(3):315-319
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Follow-up study was made on 14 patients of testicular who were treated at Severance hospital since 1972. The results are summarized as follows: 1. Among the 14 cases of testicular tumors, there were 7 cases of seminoma and 7 cases of nonseminomatous germ cell tumors(3 cases of embryonal cell carcinoma, 1 case of teratoma, 1 case of teratocarcinoma, 1 case of malignant lymphoma and 1 case of reticulum cell sarcoma.) 2. The median survival periods of 7 patients of seminoma was 35 months(range 6 to 113 months). the median survival periods of 7 patients of nonseminomatous germ cell tumor was 25 months (range 7 to 102 months). 3. The clinical stage of patient was stage A in 9, B in 3 and C in 1, The median survival periods of clinical stage A was 27.3 months, B in 51.3 months and C in 8 months. 4. Preoperative evaluation of serum AFB & HCG was made by radioimmunoassay. Only 1 case of non-seminomatous germ cell tumor had elevated serum AFB, but 2 cases of seminoma & 1 case of non-seminomatous germ cell tumor had elevated serum HCG. 5. The average survival periods according to treatment modalities was 40 months in radiation therapy(6 cases of seminoma), 10 months in chemotherapy only(3 cases of non-seminomatous germ cell tumor), 14 months in RPLND(3 cases of non-seminomatous germ cell tumor) and 16 month in RP LND with chemotherapy(2 cases of nonseminomatous germ cell tumor).
